Intrinsic Value of S&P & Nasdaq Contact Us

Tilray Brands, Inc. TLRY NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
47/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$10.00
+44.7%

Tilray Brands, Inc. (TLRY) — Analyst outlook / Analyst consensus target is. Based on 20 analyst ratings, the consensus is bullish — 5 Buy, 13 Hold, 2 Sell.

The consensus price target is $10.00, representing an upside of 44.7% from the current price $6.91.

Analysts estimate Earnings Per Share (EPS) of $-3.10 and revenue of $0.79B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-0.33 vs est $-3.10 (beat +89.3%). 2025: actual $-33.80 vs est $-11.82 (missed -185.9%). Analyst accuracy: 0%.

TLRY Stock — 12-Month Price Forecast

$10.00
▲ +44.72% Upside
Average Price Target
Based on 20 Wall Street analysts offering 12-month price targets for Tilray Brands, Inc., the price target is $10.00.
The average price target represents a +44.72% change from the last price of $6.91.

TLRY Analyst Ratings

Hold
20
Ratings
5 Buy
13 Hold
2 Sell
Based on 20 analysts giving stock ratings to Tilray Brands, Inc. in the past 3 months
Rating breakdown
Buy
5 25%
Hold
13 65%
Sell
2 10%
25%
Buy
5 analysts
65%
Hold
13 analysts
10%
Sell
2 analysts

EPS Estimates — TLRY

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$0.33 vs Est –$3.10 ▲ 838.2% off
2025 Actual –$33.80 vs Est –$11.82 ▼ 65.0% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.

Revenue Estimates — TLRY

87%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.789B vs Est $0.785B ▲ 0.5% off
2025 Actual $1.127B vs Est $0.830B ▲ 26.4% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message